NEPHROTOXICITY IN IMMUNE CHECKPOINT INHIBITOR THERAPY: A PHARMACOVIGILANCE STUDY

被引：0
|
作者：
Haeuser, Lorine
Marchese, Maya
Cone, Eugene B.
Noldus, Joachim
Bayliss, George
Kilbridge, Kerry Laing
Quoc-Dien Trinh
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP14-20
引用
收藏
页码：E261 / E262
页数：3
相关论文
共 50 条
  • [41] Toxicity in the era of immune checkpoint inhibitor therapy
    Keam, Synat
    Turner, Naimah
    Kugeratski, Fernanda G.
    Rico, Rene
    Colunga-Minutti, Jocelynn
    Poojary, Rayansh
    Alekseev, Sayan
    Patel, Anisha B.
    Li, Yuanteng Jeff
    Sheshadri, Ajay
    Loghin, Monica E.
    Woodman, Karin
    Aaroe, Ashley E.
    Hamidi, Sarah
    Iyer, Priyanka Chandrasekhar
    Palaskas, Nicolas L.
    Wang, Yinghong
    Nurieva, Roza
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [42] Nephrotoxicity of immune checkpoint inhibitor combination therapy in patients with advanced renal cell carcinoma: a meta-analysis
    Tan, An-ju
    Mo, Dun-chang
    Wu, Ka
    Pan, Hong-mei
    Wang, Dong-mei
    Xu, Xing-xin
    Chen, Min-hong
    Pan, Shu-ying
    Li, Rou
    Lian, Wen-jiao
    Wei, Meng-han
    WORLD JOURNAL OF UROLOGY, 2023, 41 (06) : 1563 - 1571
  • [43] Nephrotoxicity of immune checkpoint inhibitor combination therapy in patients with advanced renal cell carcinoma: a meta-analysis
    An-ju Tan
    Dun-chang Mo
    Ka Wu
    Hong-mei Pan
    Dong-mei Wang
    Xing-xin Xu
    Min-hong Chen
    Shu-ying Pan
    Rou Li
    Wen-jiao lian
    Meng-han Wei
    World Journal of Urology, 2023, 41 : 1563 - 1571
  • [44] Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance study
    Pascale Palassin
    Alexandre T. J. Maria
    Chayma Ladhari
    Xavier Quantin
    David Montani
    Arnaud Bourdin
    Clément Boissin
    Pierre Fesler
    Dominique Hillaire-Buys
    Philippe Guilpain
    Jean-Luc Faillie
    Cancer Immunology, Immunotherapy, 2022, 71 : 3093 - 3097
  • [45] The Occurrence of Encephalitis Due to Immune Checkpoint Inhibitors: A Pharmacovigilance Study
    Yugo Chisaki
    Hiroki Hata
    Chikako Matsumura
    Yoshitaka Yano
    Therapeutic Innovation & Regulatory Science, 2022, 56 : 323 - 332
  • [46] Association of Pulmonary Sepsis and Immune Checkpoint Inhibitors: A Pharmacovigilance Study
    Xia, Shuang
    Gong, Hui
    Zhao, Yichang
    Guo, Lin
    Wang, Yikun
    Zhang, Bikui
    Sarangdhar, Mayur
    Noguchi, Yoshihiro
    Yan, Miao
    CANCERS, 2023, 15 (01)
  • [47] Pulmonary tuberculosis associated with immune checkpoint inhibitors: a pharmacovigilance study
    Zhu, Jianhong
    He, Zhichao
    Liang, Dan
    Yu, Xiaoxia
    Qiu, Kaifeng
    Wu, Junyan
    THORAX, 2022, 77 (07) : 721 - 723
  • [48] The Occurrence of Encephalitis Due to Immune Checkpoint Inhibitors: A Pharmacovigilance Study
    Chisaki, Yugo
    Hata, Hiroki
    Matsumura, Chikako
    Yano, Yoshitaka
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2022, 56 (02) : 323 - 332
  • [49] Hemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitors: A pharmacovigilance study
    Diaz, L.
    Dillies, A. C.
    Le Souder, C.
    Guilpain, P.
    Faillie, J. L.
    Maria, A.
    Palassin, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 149 - 149
  • [50] Peripheral neuropathies under Immune Checkpoint Inhibitors: A pharmacovigilance study
    Ewig, E.
    Fournier, D.
    Palassin, P.
    Cholle, C.
    Bihan, B.
    Lebrun-Vignes, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 117 - 118
12345